** = Publikationen gelistet in SCI/SSCI/Pubmed
** Fabian, E; Stadlbauer, V; Keil, F; Hegenbarth, K; Beubler, E; Krejs, GJ
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 125: A 42-year-old man with loss of appetite, vomiting and stabbing abdominal pain.
Wien Klin Wochenschr. 2022; 134(11-12):487-496
Doi: 10.1007/s00508-022-02025-y
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H
Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
MEMO-MAG EUR MED ONC. 2019;
Doi: 10.1007/s12254-019-00542-7
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Lahousen, T; Hegenbarth, K; Ille, R; Lipp, RW; Krause, R; Little, RR; Schnedl, WJ
Determination of glycated hemoglobin in patients with advanced liver disease.
World J Gastroenterol. 2004; 10(15):2284-2286
Doi: 10.3748/wjg.v10.i15.2284
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stauber, RE; Hofer, H; Hackl, F; Schütze, K; Datz, C; Hegenbarth, K; Jessner, W; Steindl-Munda, P; Peter, F; Austrian Hepatitis Study Group
Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
WIEN KLIN WOCHENSCHR. 2004; 116(15-16): 530-535.
Doi: 10.1007/BF03217706
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Hegenbarth, K; Fickert, P; Aschauer, M; Horina, JH; Stauber, RE; Trauner, M
Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation.
Am J Gastroenterol. 2002; 97(6):1567-1568
Doi: 10.1111/j.1572-0241.2002.05750.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Ferenci, P; Brunner, H; Nachbaur, K; Datz, C; Gschwantler, M; Hofer, H; Stauber, R; Hackl, F; Jessner, W; Rosenbeiger, M; Munda-Steindl, P; Hegenbarth, K; Gangl, A; Vogel, W; Australian Hepatitis Study Group
Combination of interferon induction therapy and ribavirin in chronic hepatitis C.
Hepatology. 2001; 34(5):1006-1011
Doi: 10.1053/jhep.2001.28706
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kessler, HH; Stelzl, E; Raggam, RB; Haas, J; Kirchmeir, F; Hegenbarth, K; Daghofer, E; Santner, BI; Marth, E; Stauber, RE
Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples.
J Clin Microbiol. 2001; 39(5):1788-1790
Doi: 10.1128/JCM.39.5.1788-1790.2001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Langner, C; Thonhofer, R; Hegenbarth, K; Trauner, M
Diffuse hemangiomatosis of the liver and spleen in an adult.
Pathologe. 2001; 22(6):424-428
Doi: 10.1007/s002920100491
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Hegenbarth, K; Maurer, U; Kroisel, PM; Fickert, P; Trauner, M; Stauber, RE
No evidence for mutagenic effects of ribavirin: report of two normal pregnancies.
Am J Gastroenterol. 2001; 96(7):2286-2287
Doi: 10.1111/j.1572-0241.2001.03997.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar